A father's plea: The FDA needs to make sure that Juno's lethal disaster isn't repeated
The FDA never has publicly explained just why it decided to lift a clinical hold on Juno’s lead CAR-T drug JCAR015 just days after …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
